NasdaqGM - Nasdaq Real Time Price USD
Relay Therapeutics, Inc. (RLAY)
2.9300
+0.1200
+(4.27%)
At close: May 19 at 4:00:00 PM EDT
2.9491
+0.02
+(0.65%)
After hours: May 19 at 6:39:10 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 7 |
| Avg. Estimate | -0.47 | -0.45 | -1.79 | -1.66 |
| Low Estimate | -0.53 | -0.56 | -2.05 | -2.17 |
| High Estimate | -0.37 | -0.29 | -1.23 | -1.24 |
| Year Ago EPS | -0.69 | -0.63 | -2.36 | -1.79 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 11 | 10 |
| Avg. Estimate | 66.67k | 55.56k | 11.88M | 17.98M |
| Low Estimate | -- | -- | 7.68M | -- |
| High Estimate | 500k | 500k | 37.7M | 77.21M |
| Year Ago Sales | -- | -- | 10.01M | 11.88M |
| Sales Growth (year/est) | 0.00% | 0.00% | 18.69% | 51.39% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.73 | -0.78 | -0.55 | -0.48 |
| EPS Actual | -0.69 | -0.63 | -0.45 | -0.46 |
| Difference | 0.04 | 0.15 | 0.1 | 0.02 |
| Surprise % | 5.34% | 19.62% | 17.90% | 4.10% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.47 | -0.45 | -1.79 | -1.66 |
| 7 Days Ago | -0.49 | -0.5 | -1.81 | -1.96 |
| 30 Days Ago | -0.48 | -0.52 | -2.04 | -2.09 |
| 60 Days Ago | -0.51 | -0.57 | -2.2 | -2.29 |
| 90 Days Ago | -0.61 | -0.65 | -2.55 | -2.51 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 3 | 5 | 2 |
| Up Last 30 Days | 5 | 6 | 7 | 4 |
| Down Last 7 Days | -- | -- | 2 | -- |
| Down Last 30 Days | 2 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RLAY | 31.70% | 28.05% | 24.09% | 7.34% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 5/7/2025 |
| Initiated | Wells Fargo: Equal-Weight | 4/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/27/2025 |
| Maintains | Stifel: Buy to Buy | 2/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/14/2025 |
Related Tickers
KYMR Kymera Therapeutics, Inc.
30.20
-0.17%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2500
-0.79%
TNGX Tango Therapeutics, Inc.
2.2900
+52.67%
NRIX Nurix Therapeutics, Inc.
9.51
-0.52%
NUVB Nuvation Bio Inc.
2.3000
+1.77%
CCCC C4 Therapeutics, Inc.
1.5400
+11.59%
DAWN Day One Biopharmaceuticals, Inc.
6.48
+3.68%
ORIC ORIC Pharmaceuticals, Inc.
5.14
+8.67%
ARVN Arvinas, Inc.
6.53
+0.62%
RVMD Revolution Medicines, Inc.
39.93
+0.99%